Trials / Unknown
UnknownNCT05550506
Duloxetine on Bone Metabolism
The Effect of Duloxetine on Bone Metabolism
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (estimated)
- Sponsor
- Cukurova University · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study was to determine the effect of duloxetine as monotherapy on biochemical markers and bone mineral density.
Detailed description
51 patients diagnosed with chronic pain or fibromyalgia syndrome who were using duloxetine for at least 3 months and age and sex matched 51 healthy individuals were recruited for this cross-sectional study. Bone mineral density of both groups were measured by dual energy x ray absorbsiometry(DXA), bone biochemical markers, serum calcium, and vitamin D levels were investigated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | Patients who use duloxetine for chronic pain or fibromyalgia |
Timeline
- Start date
- 2022-07-27
- Primary completion
- 2022-10-01
- Completion
- 2022-12-25
- First posted
- 2022-09-22
- Last updated
- 2022-09-22
Locations
1 site across 1 country: Turkey (Türkiye)
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05550506. Inclusion in this directory is not an endorsement.